CS logo
small CS logo
Asklepios Westklinikum Hamburg

Hamburg, Germany
Hospital in Hamburg
Suurheid 20, 22559 Hamburg

About Asklepios Westklinikum Hamburg


"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Shire
3
Boehringer Ingelheim
2
GWT-TUD GmbH
2
Gilead Sciences
2
Asklepios proresearch
1
Intrinsic Therapeutics
1
Janssen Research & Development, LLC
1
Janssen Scientific Affairs, LLC
1
MacroGenics
1
Neovacs
1
Total Rows: 14

Clinical Trials at Asklepios Westklinikum Hamburg


During the past decade, Asklepios Westklinikum Hamburg conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112244660011110000000011Started TrialsCompleted Trails20152016201720182019202002468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
2009-09-01
2012-07-01
Completed
254
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
2011-04-01
2015-07-01
Completed
751
A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation
2010-12-17
2025-06-01
Active, not recruiting
554
Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients
2011-02-01
2014-05-01
Completed
66
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
2012-04-01
2016-06-01
Completed
472
Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine
2012-06-01
2014-06-01
Terminated
12
Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia
2011-06-01
2012-11-01
Terminated
34
Entyvio (Vedolizumab) Long Term Safety Study
2015-03-24
2021-08-03
Completed
5,302

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Asklepios Westklinikum Hamburg" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Shire" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "GWT-TUD GmbH" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Westklinikum Hamburg" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Asklepios Kliniken GmbH & Co. KGaA" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGalapagos NV: 3Galapagos NV: 3Shire: 3Shire: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2GWT-TUD GmbH: 2GWT-TUD GmbH: 2Gilead Sciences: 2Gilead Sciences: 2Asklepios proresearch: 1Asklepios proresearch: 1Intrinsic Therapeutics: 1Intrinsic Therapeutics: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Janssen Scientific Affairs, LLC: 1Janssen Scientific Affairs, LLC: 1MacroGenics: 1MacroGenics: 1

Created with Highcharts 11.1.0Top CollaboratorsGilead Sciences: 3Gilead Sciences: 3Asklepios KlinikenGmbH & Co. KGaA: 1Asklepios KlinikenGmbH & Co. KGaA: 1Bayer: 1Bayer: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Galapagos NV: 1Galapagos NV: 1Kinetic Concepts, Inc.: 1Kinetic Concepts, Inc.: 1Smith & Nephew WoundManagement Inc: 1Smith & Nephew WoundManagement Inc: 1

Clinical Trials Conditions at Asklepios Westklinikum Hamburg


According to Clinical.Site data, the most researched conditions in "Asklepios Westklinikum Hamburg" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (2 trials), "COVID-19" (1 trials) and "Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "Asklepios Westklinikum Hamburg" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Westklinikum Hamburg


Most popular intervention types in "Asklepios Westklinikum Hamburg" are "Drug" (16 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Filgotinib" (4 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Westklinikum Hamburg


The vast majority of trials in "Asklepios Westklinikum Hamburg" are 21 trials for "All" genders.

Clinical Trials Status at Asklepios Westklinikum Hamburg


Currently, there are NaN active trials in "Asklepios Westklinikum Hamburg". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Asklepios Westklinikum Hamburg, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Westklinikum Hamburg, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 5Phase 2: 5Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Active, not recruiting: 5Active, not recruiting: 5Terminated: 3Terminated: 3Enrolling by invitation: 1Enrolling by invitation: 1Unknown status: 1Unknown status: 1